natgillin/translations-raw huggingface dataset:
Regulation (EU) 2015/847 of the European Parliament and of the Council of 20 May 2015 on information accompanying transfers of funds and repealing Regulation (EC) No 1781/2006 (see page 1 of this Official Journal).
Direktiva 2013/34/EU Evropskega parlamenta in Sveta z dne 26. junija 2013 o letnih računovodskih izkazih, konsolidiranih računovodskih izkazih in povezanih poročilih nekaterih vrst podjetij, spremembi Direktive 2006/43/ES Evropskega parlamenta in Sveta ter razveljavitvi direktiv Sveta 78/660/EGS in 83/349/EGS (UL L 182, 29.6.2013, str. 19).
Directive 2009/101/EC of the European Parliament and of the Council of 16 September 2009 on coordination of safeguards which, for the protection of the interests of members and third parties, are required by Member States of companies within the meaning of the second paragraph of Article 48 of the Treaty, with a view to making such safeguards equivalent (OJ L 258, 1.10.2009, p. 11).
Uredba (EU) 2015/847 Evropskega parlamenta in Sveta z dne 20. maja 2015 o informacijah, ki spremljajo prenose sredstev, in razveljavitvi Uredbe (ES) št. 1781/2006 (glej stran 1 tega Uradnega lista).
Regulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties and trade repositories (OJ L 201, 27.7.2012, p. 1).
Direktiva 2009/101/ES Evropskega parlamenta in Sveta z dne 16. septembra 2009 o uskladitvi zaščitnih ukrepov za varovanje interesov družbenikov in tretjih oseb, ki jih države članice zahtevajo od gospodarskih družb v skladu z drugim pododstavkom člena 48 Pogodbe, zato da se oblikujejo zaščitni ukrepi z enakim učinkom v vsej Skupnosti (UL L 258, 1.10.2009, str. 11).
Directive (EU) 2015/849 of the European Parliament and of the Council of 20 May 2015 on the prevention of the use of the financial system for the purpose of money laundering or terrorist financing, amending Regulation (EU) No 648/2012 of the European Parliament and of the Council, and repealing Directive 2005/60/EC of the European Parliament and of the Council and Commission Directive 2006/70/EC (OJ L 141, 5.6.2015, p.
Uredba (EU) št. 648/2012 Evropskega parlamenta in Sveta z dne 4. julija 2012 o izvedenih finančnih instrumentih OTC, centralnih nasprotnih strankah in repozitorijih sklenjenih poslov (UL L 201, 27.7.2012, str. 1).
73).’
Direktiva (EU) 2015/849 Evropskega parlamenta in Sveta z dne 20. maja 2015 o preprečevanju uporabe finančnega sistema za pranje denarja ali financiranje terorizma, spremembi Uredbe (EU) št. 648/2012 Evropskega parlamenta in Sveta ter razveljavitvi Direktive 2005/60/ES Evropskega parlamenta in Sveta in Direktive Komisije 2006/70/ES (UL L 141, 5.6.2015, str. 73).“
The following is a non-exhaustive list of risk variables that obliged entities shall consider when determining to what extent to apply customer due diligence measures in accordance with Article 13(3):
V nadaljevanju je podan neizčrpen seznam spremenljivk tveganja, ki jih pooblaščeni subjekti upoštevajo pri določanju obsega uporabe ukrepov skrbnega preverjanja strank v skladu s členom 13(3):
the purpose of an account or relationship;
namen računa ali odnosa;
the level of assets to be deposited by a customer or the size of transactions undertaken;
višina sredstev, ki jih mora stranka položiti, ali obseg izvedenih transakcij;
the regularity or duration of the business relationship.
pravilnost ali trajanje poslovnega odnosa.
The following is a non-exhaustive list of factors and types of evidence of potentially lower risk referred to in Article 16:
V nadaljevanju je podan neizčrpen seznam dejavnikov in vrst dokazov morebitnega manjšega tveganja iz člena 16:
Customer risk factors:
Dejavniki tveganja v zvezi s strankami:
public companies listed on a stock exchange and subject to disclosure requirements (either by stock exchange rules or through law or enforceable means), which impose requirements to ensure adequate transparency of beneficial ownership;
javne družbe, ki kotirajo na borzi in za katere veljajo zahteve glede razkritja (prek borznih pravil, zakonodaje ali izvršilnih sredstev) ter ki nalagajo zahteve za zagotavljanje ustrezne preglednosti dejanskega lastništva;
public administrations or enterprises;
javne uprave ali javna podjetja;
customers that are resident in geographical areas of lower risk as set out in point (3);
stranke, ki prebivajo na geografskih območjih z manjšim tveganjem, kot je določeno v točki 3;
Product, service, transaction or delivery channel risk factors:
Dejavniki tveganja v zvezi s produkti, storitvami, transakcijami ali distribucijskimi potmi:
life insurance policies for which the premium is low;
police življenjskega zavarovanja z nizko premijo;
insurance policies for pension schemes if there is no early surrender option and the policy cannot be used as collateral;
zavarovalne police pokojninskega sistema, če ni predvidena možnost predčasnega odstopa in se polica ne more uporabiti kot dodatno jamstvo;
a pension, superannuation or similar scheme that provides retirement benefits to employees, where contributions are made by way of deduction from wages, and the scheme rules do not permit the assignment of a member's interest under the scheme;
pokojninski ali drug podoben sistem, ki zaposlenim zagotavlja pokojnine, če se prispevki vplačujejo z odtegovanjem od plače in kadar v okviru pravil sistema ni dovoljen prenos pravic na drugo osebo;
financial products or services that provide appropriately defined and limited services to certain types of customers, so as to increase access for financial inclusion purposes;
finančni produkti ali službe, ki nekaterim vrstam strank zagotavljajo ustrezno opredeljene in omejene storitve, da bi tako povečale dostop za namene finančne vključenosti;
products where the risks of money laundering and terrorist financing are managed by other factors such as purse limits or transparency of ownership (e.g. certain types of electronic money);
produkti, pri katerih se tveganja pranja denarja in financiranja terorizma obvladuje z drugimi dejavniki, kot so omejitve računa ali preglednost lastništva (npr. določene vrste elektronskega denarja);
Geographical risk factors:
Dejavniki geografskega tveganja:
third countries having effective AML/CFT systems;
tretje države, ki imajo učinkovite sisteme AML/CFT;
third countries identified by credible sources as having a low level of corruption or other criminal activity;
tretje države, za katere je na podlagi zanesljivih virov ugotovljeno, da imajo nizko stopnjo korupcije ali drugih kaznivih dejanj;
third countries which, on the basis of credible sources such as mutual evaluations, detailed assessment reports or published follow-up reports, have requirements to combat money laundering and terrorist financing consistent with the revised FATF Recommendations and effectively implement those requirements.
tretje države, ki imajo – na podlagi zanesljivih virov, kot so vzajemna vrednotenja, poročila o podrobni oceni ali objavljena poročila o nadaljnjem ukrepanju – uvedene zahteve glede boja proti pranju denarja in financiranju terorizma v skladu z revidiranimi priporočili FATF in te zahteve učinkovito izvajajo.
The following is a non-exhaustive list of factors and types of evidence of potentially higher risk referred to in Article 18(3):
V nadaljevanju je podan neizčrpen seznam dejavnikov in vrst dokazov morebitnega večjega tveganja iz člena 18(3):
the business relationship is conducted in unusual circumstances;
poslovni odnos poteka v nenavadnih okoliščinah;
customers that are resident in geographical areas of higher risk as set out in point (3);
stranke, ki prebivajo na geografskih območjih z višjim tveganjem iz točke 3;
legal persons or arrangements that are personal asset-holding vehicles;
pravne osebe ali ureditve, ki so nosilci osebnih sredstev;
companies that have nominee shareholders or shares in bearer form;
družbe, ki imajo zastopnike delničarjev ali prinosniške delnice;
businesses that are cash-intensive;
podjetja, ki so gotovinsko intenzivna;
the ownership structure of the company appears unusual or excessively complex given the nature of the company's business;
lastniška struktura družbe se zdi nenavadna ali prekomerno zapletena glede na naravo njenega poslovanja;
private banking;
zasebno bančništvo;
products or transactions that might favour anonymity;
produkti ali transakcije, pri katerih je morda zaželena anonimnost;
non-face-to-face business relationships or transactions, without certain safeguards, such as electronic signatures;
brezosebni poslovni odnosi ali transakcije brez določenih zaščitnih ukrepov, npr. elektronskega podpisa;
payment received from unknown or unassociated third parties;
plačilo, prejeto od neznanih ali nepovezanih tretjih oseb;
new products and new business practices, including new delivery mechanism, and the use of new or developing technologies for both new and pre-existing products;
novi produkti in nove poslovne prakse, vključno z novim načinom dobave, ter uporaba novih ali razvijajočih se tehnologij za nove in obstoječe produkte;
without prejudice to Article 9, countries identified by credible sources, such as mutual evaluations, detailed assessment reports or published follow-up reports, as not having effective AML/CFT systems;
brez poseganja v člen 9 države, za katere je na podlagi zanesljivih virov, kot so vzajemna vrednotenja, poročila o podrobni oceni ali objavljena poročila o nadaljnjem ukrepanju, ugotovljeno, da nimajo ustreznih sistemov AML/CFT;
countries identified by credible sources as having significant levels of corruption or other criminal activity;
države, za katere je na podlagi zanesljivih virov ugotovljeno, da imajo znatno stopnjo korupcije ali drugih kaznivih dejanj;
countries subject to sanctions, embargos or similar measures issued by, for example, the Union or the United Nations;
države, za katere veljajo sankcije, embargi ali podobni ukrepi, ki jih je izdala npr. Unija ali Združeni narodi;
countries providing funding or support for terrorist activities, or that have designated terrorist organisations operating within their country.
države, ki zagotavljajo financiranje ali podporo terorističnim organizacijam ali v katerih delujejo teroristične organizacije s seznama potrjenih terorističnih organizacij.
Directive 2005/60/EC
Direktiva 2005/60/ES
Directive 2006/70/EC
Direktiva 2006/70/ES
Article 2(3) to (9)
Člen 2(3) to (9)
Article 3(9), (10) and (11)
Člen 3(9), (10) in (11)
Articles 6 to 8
Členi 6 do 8
Articles 18 to 24
Členi 18 do 24
Articles 58 to 61
Členi 58 do 61
Where, on 25 June 2015, legal proceedings concerned with the prevention, detection, investigation or prosecution of suspected money laundering or terrorist financing are pending in a Member State, and an obliged entity holds information or documents relating to those pending proceedings, the obliged entity may retain that information or those documents, in accordance with national law, for a period of five years from 25 June 2015.
Če na dan 25. junija 2015 v državi članici poteka pravni postopek v zvezi s preprečevanjem, odkrivanjem, preiskovanjem ali preganjanjem domnevnega pranja denarja ali financiranja terorizma, pooblaščeni subjekt pa ima informacije ali dokumente v zvezi s tem tekočim sodnim postopkom, lahko pooblaščeni subjekt te informacije ali te dokumente hrani v skladu z nacionalnim pravom, in sicer za obdobje petih let od 25. junija 2015.
It is important expressly to highlight that ‘tax crimes’ relating to direct and indirect taxes are included in the broad definition of ‘criminal activity’ in this Directive, in line with the revised FATF Recommendations.
ima CNS sedež ali dovoljenje v tretji državi, za katero je Komisija v skladu z Direktivo (EU) 2015/849 Evropskega parlamenta in Sveta ugotovila, da se ne šteje, da ima strateške pomanjkljivosti v svoji nacionalni ureditvi za preprečevanje pranja denarja in financiranja terorizma, ki bi bistveno ogrožale finančni sistem Unije.
amending Annex II to Directive 2011/65/EU of the European Parliament and of the Council as regards the list of restricted substances
o spremembi Priloge II k Direktivi 2011/65/EU Evropskega parlamenta in Sveta v zvezi s seznamom omejenih snovi
Having regard to Directive 2011/65/EU of the European Parliament and of the Council of 8 June 2011 on the restriction of the use of certain hazardous substances in electrical and electronic equipment, [1] and in particular Article 6(3) thereof,
ob upoštevanju Direktive 2011/65/EU Evropskega parlamenta in Sveta z dne 8. junija 2011 o omejevanju uporabe nekaterih nevarnih snovi v električni in elektronski opremi [1] ter zlasti člena 6(3) Direktive,
Directive 2011/65/EU lays down rules on the restriction of the use of hazardous substances in electrical and electronic equipment (EEE) with a view to contributing to the protection of human health and the environment, including the environmentally sound recovery and disposal of waste EEE.
Direktiva 2011/65/EU določa pravila o omejevanju uporabe nevarnih snovi v električni in elektronski opremi (EEO), s čimer prispeva k varovanju zdravja ljudi in okolja, vključno z okolju primerno predelavo in odstranitvijo odpadne EEO.
Directive 2011/65/EU prohibits the use of lead, mercury, cadmium, hexavalent chromium, polybrominated biphenyls (PBB) and polybrominated diphenyl ethers (PBDE) in electrical and electronic equipment placed on the Union market.
Direktiva 2011/65/EU prepoveduje uporabo svinca, živega srebra, kadmija, šestvalentnega kroma, polibromiranih bifenilov (PBB) ali polibromiranih difenil etrov (PBDE) v električni in elektronski opremi, dani na trg Unije.
Annex II to that Directive lists those restricted substances.
Navedene omejene snovi so na seznamu v Prilogi II k navedeni direktivi.
The risks to human health and the environment arising from the use of Hexabromocyclododecane (HBCDD), Bis(2-ethylhexyl) phthalate (DEHP), Butyl benzyl phthalate (BBP) and Dibutyl phthalate (DBP) should be considered a priority in the periodic review of the list of restricted substances in Annex II.
Tveganja za zdravje ljudi in okolje, ki izhajajo iz uporabe heksabromociklododekana (HBCDD), di(2-etilheksil)ftalata (DEHP), benzil butil ftalata (BBP) in dibutilftalata (DBP), bi bilo treba pri rednem pregledu seznama omejenih snovi v Prilogi II obravnavati prednostno.
With a view to further restrictions, the substances that were subject to previous assessments should be re-investigated.
Z vidika nadaljnjih omejitev bi bilo treba snovi, ki so bile del predhodnih ocen, ponovno preučiti.
In accordance with Article 6(1) of Directive 2011/65/EU, interested parties, including economic operators, recyclers, treatment operators, environmental organisations and employee and consumer associations, have been consulted and a thorough assessment has been performed.
V skladu s členom 6(1) Direktive 2011/65/EU so bila opravljena posvetovanja z zainteresiranimi stranmi, vključno z gospodarskimi subjekti, podjetji za reciklažo, podjetji za obdelavo, okoljskimi organizacijami ter združenji delavcev in potrošnikov, in izvedena je bila natančna ocena.
Bis(2-ethylhexyl) phthalate (DEHP), Butyl benzyl phthalate (BBP), Dibutyl phthalate (DBP) and Diisobutyl phthalate (DIBP) are substances of very high concern (SVHC).
Di(2-etilheksil)ftalat (DEHP), benzil butil ftalat (BBP), dibutilftalat (DBP) in diizobutil ftalat (DIBP) so snovi, ki vzbujajo veliko zaskrbljenost (SVHC).
DIBP is a substance that can be used as a substitute for DBP and was subject to previous assessments performed by the Commission.
DIBP je snov, ki se lahko uporablja kot nadomestek za DBP in je bila del predhodnih ocen, ki jih je opravila Komisija.
The available evidence indicates that those four substances, when used in EEE, can have a negative impact on recycling and on human health and the environment during EEE waste management operations.
Razpoložljivi dokazi kažejo, da imajo lahko navedene štiri snovi, ko se uporabljajo v EEO, pri ravnanju z odpadno EEO negativen učinek na recikliranje ter zdravje ljudi in okolje.
Substitutes that have less negative impacts are available for DEHP, BBP, DBP and DIBP in most EEE.
Pri večini EEO so za DEHP, BBP, DBP in DIBP na voljo nadomestki z manj negativnimi učinki.
The use of those substances in EEE should therefore be restricted.
Uporabo navedenih snovi v EEO bi bilo zato treba omejiti.
DEHP, BBP and DBP are already restricted through entry 51 of Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council, [2] so that toys containing DEHP, BBP or DBP in a concentration greater than 0,1 % by weight of the plasticised material, calculated for the three phthalates cumulatively, cannot be placed on the EU market.
DEHP, BBP in DBP so že bili omejeni z vnosom 51 v Prilogi XVII k Uredbi (ES) št. 1907/2006 Evropskega parlamenta in Sveta [2], tako da igrače, ki vsebujejo DEHP, BBP ali DBP v koncentraciji, ki presega 0,1 masnega % materiala z mehčalom, izračunano kumulativno za navedene tri ftalate, ne morejo biti dane na trg EU.
In order to avoid double regulation, the restriction through entry 51 of Annex XVII to that Regulation shall therefore continue to be the only restriction applicable to DEHP, BBP and DBP in toys.
Da bi se preprečilo dvojno reguliranje, mora biti omejitev iz vnosa 51 v Prilogi XVII k navedeni uredbi še naprej edina veljavna omejitev za DEHP, BBP in DBP v igračah.
In order to facilitate transition and to mitigate possible socioeconomic impacts, an appropriate transition period should be granted, which will allow economic operators to apply for exemptions from the substance restrictions in accordance with Article 5 of Directive 2011/65/EU.
Da se olajša prehod in ublažijo možni družbenoekonomski učinki, bi bilo treba omogočiti primerno prehodno obdobje, kar bo gospodarskim subjektom omogočilo, da zaprosijo za izvzetje iz omejitev snovi v skladu s členom 5 Direktive 2011/65/EU.
The longer innovation cycles for medical devices and monitoring and control instruments should be taken into account while determining the transitional period.
Pri določitvi prehodnega obdobja bi bilo treba upoštevati daljše inovacijske cikle za medicinske pripomočke ter instrumente za spremljanje in nadzor.
The restriction of the use of DEHP, BBP, DBP and DIBP should therefore apply to medical devices, including in vitro medical devices, and monitoring and control instruments, including industrial monitoring and control instruments, from 22 July 2021.
Omejitev uporabe DEHP, BBP, DBP in DIBP bi se zato za medicinske pripomočke, vključno z in vitro medicinskimi pripomočki, ter instrumente za spremljanje in nadzor, vključno z instrumenti za spremljanje in nadzor za industrijsko uporabo, morala uporabljati od 22. julija 2021.
Any adaptation of Annex III or IV to Directive 2011/65/EU to exempt applications in relation to DEHP or DBP should take place in a manner which, in order to avoid double regulation and unnecessary burden, ensures coherence with the administration of any authorisation granted under Regulation (EC) No 1907/2006 in relation to the incorporation of those substances in EEE.
Vsaka prilagoditev prilog III ali IV k Direktivi 2011/65/EU zaradi izvzetja uporab v zvezi z DEHP ali DBP bi morala biti opravljena na način, ki zaradi preprečitve dvojnega reguliranja in nepotrebnega bremena zagotavlja skladnost z vsako avtorizacijo za vključitev navedenih snovi v EEO, podeljeno na podlagi Uredbe (ES) št. 1907/2006.
Operators considering whether to apply for exemptions under Directive 2011/65/EU should be aware that such exemptions may cover the entire life cycle of the EEE, including the manufacturing phase.
Subjekti, ki preučujejo možnost, da bi zaprosili za izvzetje na podlagi Direktive 2011/65/EU, bi morali biti pozorni na dejstvo, da lahko takšna izvzetja obsegajo celotni življenjski cikel EEO, vključno s fazo proizvodnje.
Annex II to Directive 2011/65/EU is replaced by the text in the Annex to this Directive.
Priloga II k Direktivi 2011/65/EU se nadomesti z besedilom iz Priloge k tej direktivi.
Member States shall adopt and publish, by 31 December 2016 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje do 31. decembra 2016 sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo.
They shall apply those provisions from 22 July 2019.
Navedene predpise uporabljajo od 22. julija 2019.
Restricted substances referred to in Article 4(1) and maximum concentration values tolerated by weight in homogeneous materials
Omejene snovi iz člena 4(1) in največje dovoljene vrednosti masnih koncentracij v homogenih materialih
Bis(2-ethylhexyl) phthalate (DEHP) (0,1 %)
di(2-etilheksil) ftalat (DEHP) (0,1 %)
Butyl benzyl phthalate (BBP) (0,1 %)
benzil butil ftalat (BBP) (0,1 %)
Dibutyl phthalate (DBP) (0,1 %)
dibutil ftalat (DBP) (0,1 %)
Diisobutyl phthalate (DIBP) (0,1 %)
diizobutil ftalat (DIBP) (0,1 %)
The restriction of DEHP, BBP, DBP and DIBP shall apply to medical devices, including in vitro medical devices, and monitoring and control instruments, including industrial monitoring and control instruments, from 22 July 2021.
Omejitev DEHP, BBP, DBP in DIBP se za medicinske pripomočke, vključno z in vitro medicinskimi pripomočki, ter instrumente za spremljanje in nadzor, vključno z instrumenti za spremljanje in nadzor za industrijsko uporabo, uporablja od 22. julija 2021.
The restriction of DEHP, BBP, DBP and DIBP shall not apply to cables or spare parts for the repair, the reuse, the updating of functionalities or upgrading of capacity of EEE placed on the market before 22 July 2019, and of medical devices, including in vitro medical devices, and monitoring and control instruments, including industrial monitoring and control instruments, placed on the market before 22 July 2021.
Omejitev DEHP, BBP, DBP in DIBP se ne uporablja za kable ali rezervne dele za popravilo, ponovno uporabo, nadgradnjo funkcij ali nadgradnjo zmogljivosti EEO, dane na trg pred 22. julijem 2019, in medicinskih pripomočkov, vključno z in vitro medicinskimi pripomočki, ter instrumentov za spremljanje in nadzor, vključno z instrumenti za spremljanje in nadzor za industrijsko uporabo, danih na trg pred 22. julijem 2021.
The restriction of DEHP, BBP and DBP shall not apply to toys which are already subject to the restriction of DEHP, BBP and DBP through entry 51 of Annex XVII to Regulation (EC) No 1907/2006.’
Omejitev DEHP, BBP in DBP se ne uporablja za igrače, za katere že velja omejitev za DEHP, BBP in DBP na podlagi vnosa 51 v Prilogi XVII k Uredbi (ES) št. 1907/2006.“
amending Annex II to Directive 2008/98/EC of the European Parliament and of the Council on waste and repealing certain Directives
o spremembi Priloge II k Direktivi 2008/98/ES Evropskega parlamenta in Sveta o odpadkih in razveljavitvi nekaterih direktiv
Having regard to Directive 2008/98/EC of the European Parliament and of the Council of 19 November 2008 on waste and repealing certain Directives [1] and in particular Article 38(1) thereof,
ob upoštevanju Direktive 2008/98/ES Evropskega parlamenta in Sveta z dne 19. novembra 2008 o odpadkih in razveljavitvi nekaterih direktiv [1] ter zlasti člena 38(1) Direktive,
Annex II to Directive 2008/98/EC sets out a non-exhaustive list of recovery operations.
V Prilogi II k Direktivi 2008/98/ES je določen nepopoln seznam postopkov predelave.
The R1 operation in Annex II to Directive 2008/98/EC applies to waste replacing fuel or other means to generate energy.
Postopek R1 iz Priloge II k Direktivi 2008/98/ES se uporablja za odpadke, ki nadomeščajo gorivo, ali za drug način pridobivanja energije.
This includes incineration facilities dedicated to the processing of municipal solid waste only where their energy efficiency meet the threshold established by using the energy efficiency formula (R1 formula) referred to in Annex II to Directive 2008/98/EC.
To vključuje sežigalnice za predelavo trdnih komunalnih odpadkov samo takrat, kadar njihova energetska učinkovitost dosega prag, določen z uporabo enačbe za izračun energetske učinkovitosti (enačba R1) iz Priloge II k Direktivi 2008/98/ES.